|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.155 EUR | -2.53% |
|
+0.43% | -30.21% |
| May. 27 | Ulisse Biomed, agreement with Elettrobiochimica for IVDR kit development | AN |
| May. 20 | Ulisse Biomed S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Ulisse Biomed S.p.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 0.138437 million compared to EUR 0.276628 million a year ago. Revenue was EUR 0.523777 million compared to EUR 0.41483 million a year ago.
Net loss was EUR 1.31 million compared to EUR 0.603599 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -30.21% | 27.22M | |
| +51.85% | 57.87B | |
| +41.42% | 40.25B | |
| -5.25% | 39.94B | |
| -5.16% | 28.54B | |
| +12.79% | 26.4B | |
| -20.18% | 19.33B | |
| +30.88% | 12.4B | |
| +0.61% | 12.23B | |
| +25.06% | 12.2B |
ULISSE BIOMED S.P.A. 
